Aim. Aseptic loosening is the leading cause of revision of total hip arthroplasty (THA). It is well recognized that an occult infection is the underlying cause of some aseptic revisions. Intraoperative cultures are central to the diagnosis of prosthetic joint infection (PJI). However, the diagnostic and prognostic value of unexpected positive intraoperative cultures remains unclear. The aim was to study whether first-time aseptic revision of a total hip arthroplasty with unexpected bacterial growth in cultures of intraoperatively taken biopsies have an increased risk of secondary revision due to all causes and increased risk of PJI revision, specifically. Method. Cases reported as first-time aseptic loosening revisions to the Danish Hip Arthroplasty Register (DHR) performed during January 1. st. , 2010, to May 15. th. , 2016, were included. DHR data were merged with the Danish Microbiology Database, which contains data from all intraoperatively obtained cultures in Denmark. Included first-time revisions were grouped based on the number of positive cultures growing the same bacteria genus: ≥2, 1 and 0 cultures. Revisions were followed until secondary revision, death, or end of follow-up period after one year. Relative risk for secondary revision due to all causes and PJI was estimated. Results. We included 2,305 first-time aseptic revisions. Unexpected growth was found in 282 (12%) of which 170 (60%) cases showed growth of the same bacteria in only one culture. Coagulase-negative staphylococcus accounted for 121 (71%). Secondary revision was performed in 163 (7%) cases, with PJI being the indication for revision in 43 (26%) cases. The relative risk of secondary revision was significantly higher for cases of one positive culture growing the same bacteria compared to culture negative cases, both for revision due to all causes; 1.73 (95%CI 1.07; 2.80) and PJI exclusively; 2.63 (1.16; 5.96). Cases of 2 or more biopsies culturing the same bacteria had a relative risk of all cause revision of 1.52 (0.82; 2.80). Conclusions. First-time aseptic loosening THA revisions with unexpected growth in only one biopsy culture had an increased risk of secondary revision, both due to all causes and PJI. Our findings indicate that some cases of unexpected growth of bacteria should likely be regarded as clinically significant and not sample contamination, underlining the need for more awareness and better strategies when treating patients with unexpected positive intraoperative cultures. The improved diagnosis of occult PJI in clinically aseptic THA is of great importance for future care of this large and growing patient group

Osteoporosis is common and the health and financial cost of fragility fractures is considerable. The burden of cardiovascular disease has been reduced dramatically by identifying and targeting those most at risk. A similar approach is potentially possible in the context of fragility fractures. The World Health Organization created and endorsed the use of FRAX, a fracture risk assessment tool, which uses selected risk factors to calculate a quantitative, patient-specific, ten-year risk of sustaining a fragility fracture. Treatment can thus be based on this as well as on measured bone mineral density. It may also be used to determine at-risk individuals, who should undergo bone densitometry. FRAX has been incorporated into the national osteoporosis guidelines of countries in the Americas, Europe, the Far East and Australasia. The United Kingdom National Institute for Health and Clinical Excellence also advocates its use in their guidance on the assessment of the risk of fragility fracture, and it may become an important tool to combat the health challenges posed by fragility fractures.